600789.SS · 鲁抗医药
China A-shares · RS rating 80 · As of 2026-10-14
| Price | 7.75 CNY |
|---|---|
| 1-day change | -1.0% |
| RS rating (overall / 1M / 3M / 12M) | 80 / 82 / 83 / 36 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 28 / 25 / 23 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +0.3% |
| Distance from 52-week high | +27.6% |
| Market cap (USD) | $1.3B |